1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Chronic Migraine Treatment Revenue 1.4 Market Analysis by Type 1.4.1 Global Chronic Migraine Treatment Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Drug Treatment 1.4.3 Substitution Treatment 1.5 Market by Application 1.5.1 Global Chronic Migraine Treatment Market Share by Application: 2020 VS 2026 1.5.2 Hospitals 1.5.3 Clinics 1.5.4 Others 1.6 Coronavirus Disease 2019 (Covid-19): Chronic Migraine Treatment Industry Impact 1.6.1 How the Covid-19 is Affecting the Chronic Migraine Treatment Industry 1.6.1.1 Chronic Migraine Treatment Business Impact Assessment - Covid-19 1.6.1.2 Supply Chain Challenges 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products 1.6.2 Market Trends and Chronic Migraine Treatment Potential Opportunities in the COVID-19 Landscape 1.6.3 Measures / Proposal against Covid-19 1.6.3.1 Government Measures to Combat Covid-19 Impact 1.6.3.2 Proposal for Chronic Migraine Treatment Players to Combat Covid-19 Impact 1.7 Study Objectives 1.8 Years Considered 2 Global Growth Trends by Regions 2.1 Chronic Migraine Treatment Market Perspective (2015-2026) 2.2 Chronic Migraine Treatment Growth Trends by Regions 2.2.1 Chronic Migraine Treatment Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Chronic Migraine Treatment Historic Market Share by Regions (2015-2020) 2.2.3 Chronic Migraine Treatment Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Chronic Migraine Treatment Market Growth Strategy 2.3.6 Primary Interviews with Key Chronic Migraine Treatment Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Chronic Migraine Treatment Players by Market Size 3.1.1 Global Top Chronic Migraine Treatment Players by Revenue (2015-2020) 3.1.2 Global Chronic Migraine Treatment Revenue Market Share by Players (2015-2020) 3.1.3 Global Chronic Migraine Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Chronic Migraine Treatment Market Concentration Ratio 3.2.1 Global Chronic Migraine Treatment Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Chronic Migraine Treatment Revenue in 2019 3.3 Chronic Migraine Treatment Key Players Head office and Area Served 3.4 Key Players Chronic Migraine Treatment Product Solution and Service 3.5 Date of Enter into Chronic Migraine Treatment Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Chronic Migraine Treatment Historic Market Size by Type (2015-2020) 4.2 Global Chronic Migraine Treatment Forecasted Market Size by Type (2021-2026) 5 Chronic Migraine Treatment Breakdown Data by Application (2015-2026) 5.1 Global Chronic Migraine Treatment Market Size by Application (2015-2020) 5.2 Global Chronic Migraine Treatment Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Chronic Migraine Treatment Market Size (2015-2020) 6.2 Chronic Migraine Treatment Key Players in North America (2019-2020) 6.3 North America Chronic Migraine Treatment Market Size by Type (2015-2020) 6.4 North America Chronic Migraine Treatment Market Size by Application (2015-2020) 7 Europe 7.1 Europe Chronic Migraine Treatment Market Size (2015-2020) 7.2 Chronic Migraine Treatment Key Players in Europe (2019-2020) 7.3 Europe Chronic Migraine Treatment Market Size by Type (2015-2020) 7.4 Europe Chronic Migraine Treatment Market Size by Application (2015-2020) 8 Asia-Pacific 8.1 Asia-Pacific Chronic Migraine Treatment Market Size (2015-2020) 8.2 Chronic Migraine Treatment Key Players in Asia-Pacific (2019-2020) 8.3 Asia-Pacific Chronic Migraine Treatment Market Size by Type (2015-2020) 8.4 Asia-Pacific Chronic Migraine Treatment Market Size by Application (2015-2020) (2015-2020) (2015-2020) 9 Key Players Profiles 9.1 Novartis 9.1.1 Novartis Company Details 9.1.2 Novartis Business Overview and Its Total Revenue 9.1.3 Novartis Chronic Migraine Treatment Introduction 9.1.4 Novartis Revenue in Chronic Migraine Treatment Business (2015-2020)) 9.1.5 Novartis Recent Development 9.2 Pfizer 9.2.1 Pfizer Company Details 9.2.2 Pfizer Business Overview and Its Total Revenue 9.2.3 Pfizer Chronic Migraine Treatment Introduction 9.2.4 Pfizer Revenue in Chronic Migraine Treatment Business (2015-2020) 9.2.5 Pfizer Recent Development 9.3 AstraZeneca 9.3.1 AstraZeneca Company Details 9.3.2 AstraZeneca Business Overview and Its Total Revenue 9.3.3 AstraZeneca Chronic Migraine Treatment Introduction 9.3.4 AstraZeneca Revenue in Chronic Migraine Treatment Business (2015-2020) 9.3.5 AstraZeneca Recent Development 9.4 Allergan 9.4.1 Allergan Company Details 9.4.2 Allergan Business Overview and Its Total Revenue 9.4.3 Allergan Chronic Migraine Treatment Introduction 9.4.4 Allergan Revenue in Chronic Migraine Treatment Business (2015-2020) 9.4.5 Allergan Recent Development 9.5 GlaxoSmithKline 9.5.1 GlaxoSmithKline Company Details 9.5.2 GlaxoSmithKline Business Overview and Its Total Revenue 9.5.3 GlaxoSmithKline Chronic Migraine Treatment Introduction 9.5.4 GlaxoSmithKline Revenue in Chronic Migraine Treatment Business (2015-2020) 9.5.5 GlaxoSmithKline Recent Development 9.6 Eli Lilly 9.6.1 Eli Lilly Company Details 9.6.2 Eli Lilly Business Overview and Its Total Revenue 9.6.3 Eli Lilly Chronic Migraine Treatment Introduction 9.6.4 Eli Lilly Revenue in Chronic Migraine Treatment Business (2015-2020) 9.6.5 Eli Lilly Recent Development 9.7 Merck 9.7.1 Merck Company Details 9.7.2 Merck Business Overview and Its Total Revenue 9.7.3 Merck Chronic Migraine Treatment Introduction 9.7.4 Merck Revenue in Chronic Migraine Treatment Business (2015-2020) 9.7.5 Merck Recent Development 9.8 Johnson&Johnson 9.8.1 Johnson&Johnson Company Details 9.8.2 Johnson&Johnson Business Overview and Its Total Revenue 9.8.3 Johnson&Johnson Chronic Migraine Treatment Introduction 9.8.4 Johnson&Johnson Revenue in Chronic Migraine Treatment Business (2015-2020) 9.8.5 Johnson&Johnson Recent Development 9.9 Zosano 9.9.1 Zosano Company Details 9.9.2 Zosano Business Overview and Its Total Revenue 9.9.3 Zosano Chronic Migraine Treatment Introduction 9.9.4 Zosano Revenue in Chronic Migraine Treatment Business (2015-2020) 9.9.5 Zosano Recent Development 9.10 Alder BioPharmaceuticals 9.10.1 Alder BioPharmaceuticals Company Details 9.10.2 Alder BioPharmaceuticals Business Overview and Its Total Revenue 9.10.3 Alder BioPharmaceuticals Chronic Migraine Treatment Introduction 9.10.4 Alder BioPharmaceuticals Revenue in Chronic Migraine Treatment Business (2015-2020) 9.10.5 Alder BioPharmaceuticals Recent Development 10 Analyst's Viewpoints/Conclusions 11 Appendix 11.1 Research Methodology 11.1.1 Methodology/Research Approach 11.1.2 Data Source 11.2 Disclaimer 11.3 Author Details

List of Tables Table 1. Chronic Migraine Treatment Key Market Segments Table 2. Key Players Covered: Ranking by Chronic Migraine Treatment Revenue Table 3. Ranking of Global Top Chronic Migraine Treatment Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Chronic Migraine Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Drug Treatment Table 6. Key Players of Substitution Treatment Table 7. COVID-19 Impact Global Market: (Four Chronic Migraine Treatment Market Size Forecast Scenarios) Table 8. Opportunities and Trends for Chronic Migraine Treatment Players in the COVID-19 Landscape Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis Table 10. Key Regions/Countries Measures against Covid-19 Impact Table 11. Proposal for Chronic Migraine Treatment Players to Combat Covid-19 Impact Table 12. Global Chronic Migraine Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 13. Global Chronic Migraine Treatment Market Size by Regions (US$ Million): 2020 VS 2026 Table 14. Global Chronic Migraine Treatment Market Size by Regions (2015-2020) (US$ Million) Table 15. Global Chronic Migraine Treatment Market Share by Regions (2015-2020) Table 16. Global Chronic Migraine Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 17. Global Chronic Migraine Treatment Market Share by Regions (2021-2026) Table 18. Market Top Trends Table 19. Key Drivers: Impact Analysis Table 20. Key Challenges Table 21. Chronic Migraine Treatment Market Growth Strategy Table 22. Main Points Interviewed from Key Chronic Migraine Treatment Players Table 23. Global Chronic Migraine Treatment Revenue by Players (2015-2020) (Million US$) Table 24. Global Chronic Migraine Treatment Market Share by Players (2015-2020) Table 25. Global Top Chronic Migraine Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Migraine Treatment as of 2019) Table 26. Global Chronic Migraine Treatment by Players Market Concentration Ratio (CR5 and HHI) Table 27. Key Players Headquarters and Area Served Table 28. Key Players Chronic Migraine Treatment Product Solution and Service Table 29. Date of Enter into Chronic Migraine Treatment Market Table 30. Mergers & Acquisitions, Expansion Plans Table 31. Global Chronic Migraine Treatment Market Size by Type (2015-2020) (Million US$) Table 32. Global Chronic Migraine Treatment Market Size Share by Type (2015-2020) Table 33. Global Chronic Migraine Treatment Revenue Market Share by Type (2021-2026) Table 34. Global Chronic Migraine Treatment Market Size Share by Application (2015-2020) Table 35. Global Chronic Migraine Treatment Market Size by Application (2015-2020) (Million US$) Table 36. Global Chronic Migraine Treatment Market Size Share by Application (2021-2026) Table 37. North America Key Players Chronic Migraine Treatment Revenue (2019-2020) (Million US$) Table 38. North America Key Players Chronic Migraine Treatment Market Share (2019-2020) Table 39. North America Chronic Migraine Treatment Market Size by Type (2015-2020) (Million US$) Table 40. North America Chronic Migraine Treatment Market Share by Type (2015-2020) Table 41. North America Chronic Migraine Treatment Market Size by Application (2015-2020) (Million US$) Table 42. North America Chronic Migraine Treatment Market Share by Application (2015-2020) Table 43. Europe Key Players Chronic Migraine Treatment Revenue (2019-2020) (Million US$) Table 44. Europe Key Players Chronic Migraine Treatment Market Share (2019-2020) Table 45. Europe Chronic Migraine Treatment Market Size by Type (2015-2020) (Million US$) Table 46. Europe Chronic Migraine Treatment Market Share by Type (2015-2020) Table 47. Europe Chronic Migraine Treatment Market Size by Application (2015-2020) (Million US$) Table 48. Europe Chronic Migraine Treatment Market Share by Application (2015-2020) Table 49. Asia-Pacific Key Players Chronic Migraine Treatment Revenue (2019-2020) (Million US$) Table 50. Asia-Pacific Key Players Chronic Migraine Treatment Market Share (2019-2020) Table 51. Asia-Pacific Chronic Migraine Treatment Market Size by Type (2015-2020) (Million US$) Table 52. Asia-Pacific Chronic Migraine Treatment Market Share by Type (2015-2020) Table 53. Asia-Pacific Chronic Migraine Treatment Market Size by Application (2015-2020) (Million US$) Table 54. Asia-Pacific Chronic Migraine Treatment Market Share by Application (2015-2020) Table 55. Novartis Company Details Table 56. Novartis Business Overview Table 57. Novartis Product Table 58. Novartis Revenue in Chronic Migraine Treatment Business (2015-2020) (Million US$) Table 59. Novartis Recent Development Table 60. Pfizer Company Details Table 61. Pfizer Business Overview Table 62. Pfizer Product Table 63. Pfizer Revenue in Chronic Migraine Treatment Business (2015-2020) (Million US$) Table 64. Pfizer Recent Development Table 65. AstraZeneca Company Details Table 66. AstraZeneca Business Overview Table 67. AstraZeneca Product Table 68. AstraZeneca Revenue in Chronic Migraine Treatment Business (2015-2020) (Million US$) Table 69. AstraZeneca Recent Development Table 70. Allergan Company Details Table 71. Allergan Business Overview Table 72. Allergan Product Table 73. Allergan Revenue in Chronic Migraine Treatment Business (2015-2020) (Million US$) Table 74. Allergan Recent Development Table 75. GlaxoSmithKline Company Details Table 76. GlaxoSmithKline Business Overview Table 77. GlaxoSmithKline Product Table 78. GlaxoSmithKline Revenue in Chronic Migraine Treatment Business (2015-2020) (Million US$) Table 79. GlaxoSmithKline Recent Development Table 80. Eli Lilly Company Details Table 81. Eli Lilly Business Overview Table 82. Eli Lilly Product Table 83. Eli Lilly Revenue in Chronic Migraine Treatment Business (2015-2020) (Million US$) Table 84. Eli Lilly Recent Development Table 85. Merck Company Details Table 86. Merck Business Overview Table 87. Merck Product Table 88. Merck Revenue in Chronic Migraine Treatment Business (2015-2020) (Million US$) Table 89. Merck Recent Development Table 90. Johnson&Johnson Business Overview Table 91. Johnson&Johnson Product Table 92. Johnson&Johnson Company Details Table 93. Johnson&Johnson Revenue in Chronic Migraine Treatment Business (2015-2020) (Million US$) Table 94. Johnson&Johnson Recent Development Table 95. Zosano Company Details Table 96. Zosano Business Overview Table 97. Zosano Product Table 98. Zosano Revenue in Chronic Migraine Treatment Business (2015-2020) (Million US$) Table 99. Zosano Recent Development Table 100. Alder BioPharmaceuticals Company Details Table 101. Alder BioPharmaceuticals Business Overview Table 102. Alder BioPharmaceuticals Product Table 103. Alder BioPharmaceuticals Revenue in Chronic Migraine Treatment Business (2015-2020) (Million US$) Table 104. Alder BioPharmaceuticals Recent Development Table 105. Research Programs/Design for This Report Table 106. Key Data Information from Secondary Sources Table 107. Key Data Information from Primary Sources List of Figures Figure 1. Global Chronic Migraine Treatment Market Share by Type: 2020 VS 2026 Figure 2. Drug Treatment Features Figure 3. Substitution Treatment Features Figure 4. Global Chronic Migraine Treatment Market Share by Application: 2020 VS 2026 Figure 5. Hospitals Case Studies Figure 6. Clinics Case Studies Figure 7. Others Case Studies Figure 8. Chronic Migraine Treatment Report Years Considered Figure 9. Global Chronic Migraine Treatment Market Size YoY Growth 2015-2026 (US$ Million) Figure 10. Global Chronic Migraine Treatment Market Share by Regions: 2020 VS 2026 Figure 11. Global Chronic Migraine Treatment Market Share by Regions (2021-2026) Figure 12. Porter's Five Forces Analysis Figure 13. Global Chronic Migraine Treatment Market Share by Players in 2019 Figure 14. Global Top Chronic Migraine Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Migraine Treatment as of 2019 Figure 15. The Top 10 and 5 Players Market Share by Chronic Migraine Treatment Revenue in 2019 Figure 16. North America Chronic Migraine Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 17. Europe Chronic Migraine Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 18. Asia-Pacific Chronic Migraine Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Novartis Total Revenue (US$ Million): 2019 Compared with 2018 Figure 20. Novartis Revenue Growth Rate in Chronic Migraine Treatment Business (2015-2020) Figure 21. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 22. Pfizer Revenue Growth Rate in Chronic Migraine Treatment Business (2015-2020) Figure 23. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018 Figure 24. AstraZeneca Revenue Growth Rate in Chronic Migraine Treatment Business (2015-2020) Figure 25. Allergan Total Revenue (US$ Million): 2019 Compared with 2018 Figure 26. Allergan Revenue Growth Rate in Chronic Migraine Treatment Business (2015-2020) Figure 27. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. GlaxoSmithKline Revenue Growth Rate in Chronic Migraine Treatment Business (2015-2020) Figure 29. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. Eli Lilly Revenue Growth Rate in Chronic Migraine Treatment Business (2015-2020) Figure 31. Merck Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. Merck Revenue Growth Rate in Chronic Migraine Treatment Business (2015-2020) Figure 33. Johnson&Johnson Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. Johnson&Johnson Revenue Growth Rate in Chronic Migraine Treatment Business (2015-2020) Figure 35. Zosano Total Revenue (US$ Million): 2019 Compared with 2018 Figure 36. Zosano Revenue Growth Rate in Chronic Migraine Treatment Business (2015-2020) Figure 37. Alder BioPharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 38. Alder BioPharmaceuticals Revenue Growth Rate in Chronic Migraine Treatment Business (2015-2020) Figure 39. Bottom-up and Top-down Approaches for This Report Figure 40. Data Triangulation Figure 41. Key Executives Interviewed

Novartis Pfizer AstraZeneca Allergan GlaxoSmithKline Eli Lilly Merck Johnson&Johnson Zosano Alder BioPharmaceuticals